DealsDRI Healthcare Trust buys portion of Editas’ drug tech payment rightsThe upfront purchase price was $57 million.ByIrien Joseph7 October 2024•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsCanadaNorth AmericaHealthcareBriefs